Hyphens Pharma International Limited Sustainability Profile
Hyphens Pharma International Limited, often referred to as Hyphens Pharma, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Singapore (SG). Established in 2001, the company has made significant strides in providing innovative healthcare solutions across Asia, with a focus on specialty pharmaceuticals and consumer health products. Hyphens Pharma is renowned for its unique portfolio, which includes prescription medicines, over-the-counter products, and nutraceuticals. The company distinguishes itself through strategic partnerships and a commitment to quality, ensuring that its offerings meet the highest standards of efficacy and safety. With a strong market position, Hyphens Pharma has achieved notable milestones, including expanding its operational reach and enhancing its product line to cater to diverse healthcare needs.
DitchCarbon Score
How does Hyphens Pharma International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hyphens Pharma International Limited's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hyphens Pharma International Limited's reported carbon emissions
In 2024, Hyphens Pharma International Limited reported total carbon emissions of approximately 470,200 kg CO2e, comprising 26,200 kg CO2e from Scope 1 and 444,000 kg CO2e from Scope 2 emissions. This marks a slight increase from 2023, when the company recorded total emissions of about 408,700 kg CO2e, with 10,700 kg CO2e from Scope 1 and 398,000 kg CO2e from Scope 2. Hyphens Pharma has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or initiatives as part of their climate commitments. The company’s emissions data is not cascaded from any parent organization, indicating that these figures are independently reported. The GHG emissions intensity for Hyphens Pharma stands at approximately 0.0024 tCO2e per million USD in revenue, reflecting their operational efficiency in relation to carbon output. As of now, the company has not established any formal climate pledges or commitments to reduce emissions, positioning them within an industry context that increasingly prioritises sustainability and carbon neutrality.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 10,700 | 00,000 |
| Scope 2 | 398,000 | 000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Hyphens Pharma International Limited's Industry?
How Carbon Intensive is Hyphens Pharma International Limited's Location?
Hyphens Pharma International Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hyphens Pharma International Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
